HSP Research Foundation
Welcome to the HSP Research Foundation – created in 2005 to find an effective treatment for Hereditary Spastic Paraplegia (HSP) – an inherited, degenerative disease affecting mainly the legs, causing spasticity, muscle weakness and severely impairing walking.
The HSP Research Foundation is an incorporated, registered Australian charity that facilitates and funds research to find an effective treatment. The Foundation is also the community hub for HSPers in Australia, creating awareness and providing information, education and support. Read More »
Winter Edition 2020
Spring edition to be published early September 2020
Importance of lipid droplet metabolism in HSP
Fundamental processes and potential drug targets
1 commentNew HSP genotypes and phenotypes
Research from Poland, Sudan, Spain, Iran, Korea, China, Czech Republic, Taiwan, Turkey, Mexico and Italy
Your Say »
This space is for you to have your say. Email us
Foundation Research Team
Here are the researchers working on the HSP Research Program facilitated and funded by the Foundation
Fundraising for HSP Research
Pre-clinical investigations leading into clinical trials are the current focus of the HSP Research Program. The aim is to find out if the drug treatment effective with HSP stem cells in the lab is effective with HSPers themselves.
There are technical, medical, ethical, regulatory, logistical, legal, financial and organisational challenges to address and take action on. Biomarker studies to find a measure for HSP are underway and drug dose range finding studies are now completed.
Consistent funding support helps attract outside funding. We need to reach $120,000 again in 2020.
An effective treatment for HSP is now within reach!
